Search Results

There are 10900 results for: content related to: Structural characterization and aging of glassy pharmaceuticals made using acoustic levitation

  1. Nanoassembly of Probucol Enables Novel Therapeutic Efficacy in the Suppression of Lung Metastasis of Breast Cancer


    Volume 10, Issue 22, November 26, 2014, Pages: 4735–4745, Zhiwen Zhang, Haiqiang Cao, Shijun Jiang, Zeying Liu, Xinyu He, Haijun Yu and Yaping Li

    Version of Record online : 16 JUN 2014, DOI: 10.1002/smll.201400799

  2. You have full text access to this OnlineOpen article
    Probucol ameliorates renal and metabolic sequelae of primary CoQ deficiency in Pdss2 mutant mice

    EMBO Molecular Medicine

    Volume 3, Issue 7, July 2011, Pages: 410–427, Marni J. Falk, Erzsebet Polyak, Zhe Zhang, Min Peng, Rhonda King, Jonathan S. Maltzman, Ezinne Okwuego, Oksana Horyn, Eiko Nakamaru-Ogiso, Julian Ostrovsky, Letian X. Xie, Jia Yan Chen, Beth Marbois, Itzhak Nissim, Catherine F. Clarke and David L. Gasser

    Version of Record online : 8 JUN 2011, DOI: 10.1002/emmm.201100149

  3. On the mechanism of selective action of probucol on the inwardly rectifying potassium current in GH3 lactotrophs

    Drug Development Research

    Volume 54, Issue 1, September 2001, Pages: 1–11, Hung-Ting Chiang and Sheng-Nan Wu

    Version of Record online : 2 NOV 2001, DOI: 10.1002/ddr.1198

  4. Probucol inhibits intercellular adhesion molecule-1 expression on cultured rat mesangial cells


    Volume 4, Issue 1-2, January 1998, Pages: 75–80, Toshihiro SUGIURA, Akira WADA, Atsushi YAMAUCHI, Masaru HORIO, Enyu IMAI and Masatsugu HORI

    Version of Record online : 28 JUN 2008, DOI: 10.1111/j.1440-1797.1998.tb00324.x

  5. Probucol combined with valsartan in immunoglobulin A nephropathy: A multi-centre, open labelled, randomized controlled study


    Volume 19, Issue 1, January 2014, Pages: 40–46, Zhiming Ye, Li Zhang, Lixia Xu, Wei Shi, Haitang Hu, Xiaofeng Shi, Weiqiang Zhong, Shuan Hou, Honghong Yan, Bin Zhang, Yunfeng Xia, Wenjian Wang, Zonglin Feng, Liping Wang and Yongzheng Liang

    Version of Record online : 17 DEC 2013, DOI: 10.1111/nep.12177

  6. You have free access to this content
    Induction of NAD(P)H:quinone Reductase by Probucol: A Possible Mechanism for Protection against Chemical Carcinogenesis and Toxicity

    Pharmacology & Toxicology

    Volume 93, Issue 6, December 2003, Pages: 259–263, Mohammad Iqbal and Shigeru Okada

    Version of Record online : 11 DEC 2003, DOI: 10.1111/j.1600-0773.2003.pto930602.x

  7. Probucol Prevents Atrial Remodeling by Inhibiting Oxidative Stress and TNF-α/NF-κB/TGF-β Signal Transduction Pathway in Alloxan-Induced Diabetic Rabbits

    Journal of Cardiovascular Electrophysiology

    Volume 26, Issue 2, February 2015, Pages: 211–222, HUAYING FU, GUANGPING LI, CHANGLE LIU, JIAN LI, XINGHUA WANG, LIJUN CHENG and TONG LIU

    Version of Record online : 17 OCT 2014, DOI: 10.1111/jce.12540

  8. Differential effects of probucol on two distinct experimental rat nephrosis models


    Volume 5, Issue 3, October 2000, Pages: 187–192, H Nakahama, K Obata and M Sugita

    Version of Record online : 9 OCT 2008, DOI: 10.1046/j.1440-1797.2000.00012.x

  9. You have full text access to this Open Access content
    An Antioxidant, Probucol, Induces Anti-angiogenesis and Apoptosis in Athymic Nude Mouse Xenografted Human Head and Neck Squamous Carcinoma Cells

    Japanese Journal of Cancer Research

    Volume 90, Issue 11, November 1999, Pages: 1224–1230, Goshi Nishimura, Syunsuke Yanoma, Hiromi Mizuno, Koji Kawakami and Mamoru Tsukuda

    Version of Record online : 23 AUG 2005, DOI: 10.1111/j.1349-7006.1999.tb00700.x

  10. Location of Probucol in Lipoproteins Inferred from Compositional Analysis of Lipoprotein Particles. An In-vitro Study

    Journal of Pharmacy and Pharmacology

    Volume 46, Issue 10, October 1994, Pages: 797–800, JEAN-MARIE BARD, SAÎK URIEN, JEAN-CHARLES FRUCHART and JEAN-PAUL TILLEMENT

    Version of Record online : 12 APR 2011, DOI: 10.1111/j.2042-7158.1994.tb03732.x

  11. Probucol attenuates ethanol-induced liver fibrosis in rats by inhibiting oxidative stress, extracellular matrix protein accumulation and cytokine production

    Clinical and Experimental Pharmacology and Physiology

    Volume 41, Issue 1, January 2014, Pages: 73–80, Xuesong Su, Yanqiu Wang, Guangyu Zhou, Xu Yang, Rui Yu, Yan Lin and Changqing Zheng

    Version of Record online : 30 DEC 2013, DOI: 10.1111/1440-1681.12182

  12. You have free access to this content
    Probucol attenuates the development of aortic atherosclerosis in cholesterol-fed rabbits

    British Journal of Pharmacology

    Volume 98, Issue 2, October 1989, Pages: 612–618, Alan Daugherty, Ben S. Zweifel and Gustav Schonfeld

    Version of Record online : 19 JUL 2012, DOI: 10.1111/j.1476-5381.1989.tb12635.x

  13. Pharmacokinetics of probucol in male rats

    Journal of Pharmaceutical Sciences

    Volume 73, Issue 12, December 1984, Pages: 1758–1763, Joel F. Heeg, Michael F. Hiser, Darlene K. Satonin and James Q. Rose

    Version of Record online : 17 SEP 2006, DOI: 10.1002/jps.2600731225

  14. You have free access to this content
    Protection of chylomicron remnants from oxidation by incorporation of probucol into the particles enhances their uptake by human macrophages and increases lipid accumulation in the cells

    European Journal of Biochemistry

    Volume 271, Issue 12, June 2004, Pages: 2417–2427, Elizabeth H. Moore, Mariarosaria Napolitano, Michael Avella, Fatos Bejta, Keith E. Suckling, Elena Bravo and Kathleen M. Botham

    Version of Record online : 20 MAY 2004, DOI: 10.1111/j.1432-1033.2004.04164.x

  15. Effects of Long-Term Treatment with Probucol on Serum Lipoproteins in Cases of Familial Hypercholesterolemia in the Elderly

    Journal of the American Geriatrics Society

    Volume 38, Issue 1, January 1990, Pages: 15–18, Nobuhiro Morisaki, Seijiro Mori, Junji Kobayashi, Yo Ishikawa, Masaki Shinomiya, Kohji Shirai, Yasushi Saito and Sho Yoshida

    Version of Record online : 27 APR 2015, DOI: 10.1111/j.1532-5415.1990.tb01590.x

  16. Long-Term Oral Administration of Probucol [4, 4‘-(Isopropylidenedithio) bis (2, 6-di-t-Butylphenol)] (DH-581) in the Management of Hypercholesterolemia

    Journal of the American Geriatrics Society

    Volume 22, Issue 4, April 1974, Pages: 167–175, ROBERT S. HARRIS JR, HUGH R. GILMORE III, LEE A. BRICKER, IRIS M. KIEM and EDWARD RUBIN

    Version of Record online : 27 APR 2015, DOI: 10.1111/j.1532-5415.1974.tb02163.x

  17. Efficacy of probucol for the treatment of non-alcoholic steatohepatitis with dyslipidemia: An open-label pilot study

    Hepatology Research

    Volume 44, Issue 4, April 2014, Pages: 429–435, Tomokazu Ishitobi, Hideyuki Hyogo, Hironori Tokumo, Koji Arihiro and Kazuaki Chayama

    Version of Record online : 15 MAY 2013, DOI: 10.1111/hepr.12135

  18. Probucol: Pharmacology and Clinical Application

    The Journal of Clinical Pharmacology

    Volume 30, Issue 1, January 1990, Pages: 3–9, Peter Zimetbaum, Howard Eder and William Frishman

    Version of Record online : 8 MAR 2013, DOI: 10.1002/j.1552-4604.1990.tb03431.x

  19. Vitamin E supplementation alters HDL-cholesterol concentration and paraoxonase activity in rabbits fed high-cholesterol diet: Comparison with probucol

    Journal of Biochemical and Molecular Toxicology

    Volume 19, Issue 5, November 2005, Pages: 336–346, Seon-Min Jeon, Yong Bok Park, Oh-Shin Kwon, Tae-Lin Huh, Won-Ha Lee, Kyung-Min Do, Taesun Park and Myung-Sook Choi

    Version of Record online : 16 NOV 2005, DOI: 10.1002/jbt.20098

  20. A Comparative Study of the Therapeutic Effect of Probucol and Pravastatin on Xanthelasma

    The Journal of Dermatology

    Volume 23, Issue 9, September 1996, Pages: 598–602, Masaru Fujita and Kohji Shirai

    Version of Record online : 9 APR 2015, DOI: 10.1111/j.1346-8138.1996.tb02661.x